Assoz. Prof. Mag. Dr. Johannes Kirchmair
Johannes Kirchmair
21 - 40 out of 127
Morger A, Garcia de Lomana M, Norinder U, Svensson F, Kirchmair J, Mathea M et al. Studying and mitigating the effects of data drifts on ML model performance at the example of chemical toxicity data. Scientific Reports. 2022 May 4;12(1):7244. doi: 10.1038/s41598-022-09309-3

Lomana MGD, Svensson F, Volkamer A, Mathea M, Kirchmair J. Consideration of predicted small-molecule metabolites in computational toxicology. Digital Discovery. 2022 Apr 1;1(2):158-172. doi: https://doi.org/10.1039/D1DD00018G

Hirte S, Burk O, Tahir A, Schwab M, Windshügel B, Kirchmair J. Development and Experimental Validation of Regularized Machine Learning Models Detecting New, Structurally Distinct Activators of PXR. Cells. 2022 Apr;11(8):1253. doi: 10.3390/cells11081253

Kirchweger B, Klein-Junior LC, Pretsch D, Chen Y, Cretton S, Gasper AL et al. Azepine-Indole Alkaloids From Psychotria nemorosa Modulate 5-HT2A Receptors and Prevent in vivo Protein Toxicity in Transgenic Caenorhabditis elegans. Frontiers in Neuroscience. 2022 Mar 14;16:826289. doi: 10.3389/fnins.2022.826289




Plonka W, Stork C, Šícho M, Kirchmair J. CYPlebrity: Machine learning models for the prediction of inhibitors of cytochrome P450 enzymes. Bioorganic & Medicinal Chemistry. 2021 Sep 15;46:116388. Epub 2021 Aug 28. doi: 10.1016/j.bmc.2021.116388

Ntie-Kang F, Telukunta KK, Fobofou SAT, Chukwudi Osamor V, Egieyeh SA, Valli M et al. Computational Applications in Secondary Metabolite Discovery (CAiSMD): an online workshop. Journal of Cheminformatics. 2021 Sep 6;13(1):64. doi: 10.1186/s13321-021-00546-8




Wilm A, Lomana MGD, Stork C, Mathai N, Hirte S, Norinder U et al. Predicting the Skin Sensitization Potential of Small Molecules with Machine Learning Models Trained on Biologically Meaningful Descriptors. Pharmaceuticals. 2021 Aug;14(8):790. doi: 10.3390/ph14080790

Paraschiakos T, Flat W, Chen Y, Kirchmair J, Windhorst S. Mechanism of BIP-4 mediated inhibition of InsP3Kinase-A. Bioscience Reports. 2021 Jul;41(7):BSR20211259. Epub 2021 Jul 7. doi: 10.1042/BSR20211259

Garcia de Lomana M, Morger A, Norinder U, Buesen R, Landsiedel R, Volkamer A et al. ChemBioSim: Enhancing Conformal Prediction of In Vivo Toxicity by Use of Predicted Bioactivities. Journal of Chemical Information and Modeling. 2021 Jun 21;61(7):3255–3272. doi: 10.1021/acs.jcim.1c00451

Medina-Franco JL, Martinez-Mayorga K, Gortari EF, Kirchmair J, Bajorath J. Rationality over fashion and hype in drug design. F1000Research. 2021 May 18;10:397. doi: 10.12688/f1000research.52676.1

Ingwersen T, Linnenberg C, D'Acunto E, Temori S, Paolucci I, Wasilewski D et al. G392E neuroserpin causing the dementia FENIB is secreted from cells but is not synaptotoxic. Scientific Reports. 2021 Apr 22;11(1):8766. doi: 10.1038/s41598-021-88090-1

Li S, Ding Y, Chen M, Chen Y, Kirchmair J, Zhu Z et al. HDAC3i-Finder: A Machine Learning-based Computational Tool to Screen for HDAC3 Inhibitors. Molecular Informatics. 2021 Mar;40(3):2000105. Epub 2020 Oct 16. doi: 10.1002/minf.202000105

de Bruyn Kops C, Šícho M, Mazzolari A, Kirchmair J. GLORYx: Prediction of the Metabolites Resulting from Phase 1 and Phase 2 Biotransformations of Xenobiotics. Chemical Research in Toxicology. 2021 Feb 15;34(2):286-299. Epub 2020 Aug 10. doi: 10.1021/acs.chemrestox.0c00224

Garcia de Lomana M, Weber AG, Birk B, Landsiedel R, Achenbach J, Schleifer K-J et al. In Silico Models to Predict the Perturbation of Molecular Initiating Events Related to Thyroid Hormone Homeostasis. Chemical Research in Toxicology. 2021 Feb 15;34(2):396-411. Epub 2020 Nov 13. doi: 10.1021/acs.chemrestox.0c00304

21 - 40 out of 127

Maximizing the performance of similarity-based virtual screening methods

Johannes Kirchmair (Speaker)

19 Apr 2023

Activity: Talks and presentationsTalk or oral contributionScience to Science


In silico methods for flagging compounds that are likely to interfere with biological assays

Johannes Kirchmair (Invited speaker)

16 Dec 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Cheminformatics in natural product-based drug discovery

Johannes Kirchmair (Invited speaker)

24 Nov 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


From in silico to in vivo - Psychotria nemorosa alkaloids counter protein toxicity in Caenorhabditis elegans

Benjamin Kirchweger (Speaker), Luiz C Klein-Junior (Contributor), Dagmar Pretsch (Contributor), Ya Chen (Contributor), Sylvian Cretton (Contributor), Andre Luis de Gasper (Contributor), Yvan Vander Heyden (Contributor), Philippe Christen (Contributor), Johannes Kirchmair (Contributor), Amélia T Henriques (Contributor) & Judith Maria Rollinger (Contributor)

31 Aug 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Natural products against SARS-CoV-2 or how to catch a butterfly?

Andreas Wasilewicz (Speaker), Benjamin Kirchweger (Contributor), Denisa Bojkova (Contributor), Marie Jose Abi Saad (Contributor), Julia Langeder (Contributor), Ulrike Grienke (Contributor), Jindrich Cinatl (Contributor), Julien Orts (Contributor), Johannes Kirchmair (Contributor), Holger F. Rabenau (Contributor) & Judith Maria Rollinger (Contributor)

31 Aug 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Cheminformatics in Natural Product-Based Drug Discovery

Johannes Kirchmair (Keynote speaker)

30 Aug 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computerbasierte Vorhersage des Metabolismus von Wirkstoffen

Johannes Kirchmair (Invited speaker)

12 Jul 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Cheminformatics in natural product-based drug discovery

Johannes Kirchmair (Invited speaker)

30 Jun 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Introduction to machine learning in early drug discovery

Johannes Kirchmair (Invited speaker)

21 Jun 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


In silico and in vitro Approach to Assess Direct Allosteric AMPK Activators from Nature

Benjamin Kirchweger (Speaker), Andreas Wasilewicz (Contributor), Katrin Fischhuber (Contributor), Ammar Tahir (Contributor), Ya Chen (Contributor), Elke Heiß (Contributor), Thierry Langer (Contributor), Johannes Kirchmair (Contributor) & Judith Maria Rollinger (Contributor)

20 May 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


In silico prediction of xenobiotic metabolism

Johannes Kirchmair (Invited speaker)

19 May 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


In silico prediction of drug metabolism

Johannes Kirchmair (Invited speaker)

4 May 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computational prediction of the metabolic fate of small molecules

Johannes Kirchmair (Speaker)

28 Sep 2021

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computational methods for flagging compounds likely to cause false outcomes in biological assays

Johannes Kirchmair (Speaker)

7 Jun 2021

Activity: Talks and presentationsTalk or oral contributionScience to Science


In silico prediction of the macromolecular targets of natural products

Johannes Kirchmair (Speaker)

9 Mar 2021

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computational prediction of xenobiotic metabolism (focus on AI/machine learning methods)

Johannes Kirchmair (Speaker)

27 Jan 2021

Activity: Talks and presentationsTalk or oral contributionScience to Science


Department of Pharmaceutical Sciences

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien

T: +43-1-4277-55104

johannes.kirchmair@univie.ac.at